Health

With Merck's oral PCSK9 inhibitor demonstrating strong phase 3 trial results, J AND J's IL23R antagonist peptide continuing its...

2024 was pivotal for TCR therapies. Following the commercial approval for Adaptimmune's Tecelra, positive clinical readouts, and FIH trials...

With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics. Whether...

INTERPHEX provides direct access to the tools and resources to accelerate your drug-to-market journey efficiently and effectively. INTERPHEX bridges...

The 4th Annual Mayo Clinic Specialty Updates for the Generalist Team 2025 at the Margaritaville Resort Orlando is a...

This course covers a broad range of subjects in diagnostic pathology including, but not limited to, breast, genitourinary, gynecologic,...

The second Mayo Clinic Advanced Surgical Technologies and Robotics symposium provides updates on many surgical and medical disciplines, with...

Advance the field and improve patient outcomes for free and from the comfort of your own home or office....

Mayo Clinic's Critical Care Review for the Nurse Practitioner and Physician Assistant is an interactive course designed for advanced...